Publication Name	World Journal of Radiology
Manuscript ID	7637
Country	Germany

Received	2013-11-27 15:46
Peer-Review Started	2013-11-27 21:38
To Make the First Decision	2014-03-12 16:58
Return for Revision	2014-03-20 20:09
Revised
Second Decision	2014-05-16 17:34
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-05-16 17:53
Articles in Press	2014-05-23 12:36
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-07-11 15:44
Publish the Manuscript Online	2014-07-31 11:53

ISSN	1949-8470 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Radiology, Nuclear Medicine & Medical Imaging
Manuscript Type	Minireviews
Article Title	Clinical use of bone-targeting radiopharmaceuticals with focus on alpha-emitters
Manuscript Source	Invited Manuscript
All Author List	Hinrich A Wieder, Michael Lassmann, Martin S Allen-Auerbach, Johannes Czernin and Ken Herrmann
Funding Agency and Grant Number
Corresponding Author	Hinrich A Wieder, MD, Department of Radiology, Zentrum für Radiologie und Nuklearmedizin, Zentrum für Radiologie und Nuklearmedizin, Von-Werth-Stra?e 5, 41515 Grevenbroich, Germany. h@wieder.de
Key Words	Radium; Bone targeted radiopharmaceuticals; Alpha emitters
Core Tip	The incidence rate of prostate cancer worldwide is high. Ninety percent of patients dying of prostate cancer have bone metastases with varying symptoms which are significantly impairing their quality of life. 223Radium is the first therapeutic that results in a survival benefit for patients with bone metastatic, castrate resistant prostate cancer. 223Radium was also associated with low myelosuppression rates and fewer adverse events.This article provides an overview of the pre-clinical and clinical trials with 223Radium.
Publish Date	2014-07-31 11:53
Citation	Wieder HA, Lassmann M, Allen-Auerbach M, Czernin J, Herrmann K. Clinical use of bone-targeting radiopharmaceuticals with focus on alpha-emitters. World J Radiol 2014; 6(7): 480-485
URL	http://www.wjgnet.com/1949-8470/full/v6/i7/480.htm
DOI	http://dx.doi.org/10.4329/wjr.v6.i7.480

Full Article (PDF)	WJR-6-480.pdf
Full Article (Word)	WJR-6-480.doc
Manuscript File	7637-Review.docx
Answering Reviewers	7637-Answering reviewers.pdf
Copyright License Agreement	7637-Copyright assignment.pdf
Peer-review Report	7637-Peer review(s).pdf
Scientific Editor Work List	7637-Scientific editor work list.pdf